DEXELANCE SPA (DEX.MI) Fundamental Analysis & Valuation

BIT:DEX • IT0005543480

Current stock price

2.59 EUR
-0.03 (-1.15%)
Last:

This DEX.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. DEX.MI Profitability Analysis

1.1 Basic Checks

  • In the past year DEX has reported negative net income.
  • DEX had a positive operating cash flow in the past year.
  • In multiple years DEX reported negative net income over the last 5 years.
  • Each year in the past 5 years DEX had a positive operating cash flow.
DEX.MI Yearly Net Income VS EBIT VS OCF VS FCFDEX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 20M -20M

1.2 Ratios

  • DEX has a worse Return On Assets (-4.07%) than 81.25% of its industry peers.
  • DEX has a Return On Equity of -14.86%. This is amonst the worse of the industry: DEX underperforms 81.25% of its industry peers.
Industry RankSector Rank
ROA -4.07%
ROE -14.86%
ROIC N/A
ROA(3y)2.15%
ROA(5y)1.95%
ROE(3y)5.6%
ROE(5y)4.9%
ROIC(3y)N/A
ROIC(5y)N/A
DEX.MI Yearly ROA, ROE, ROICDEX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 5 -5 10 -10 15

1.3 Margins

  • Looking at the Gross Margin, with a value of 35.22%, DEX is in line with its industry, outperforming 53.13% of the companies in the same industry.
  • DEX's Gross Margin has declined in the last couple of years.
  • DEX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.52%
GM growth 5Y-2.42%
DEX.MI Yearly Profit, Operating, Gross MarginsDEX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. DEX.MI Health Analysis

2.1 Basic Checks

  • DEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for DEX has been reduced compared to 1 year ago.
  • DEX has less shares outstanding than it did 5 years ago.
  • DEX has a worse debt/assets ratio than last year.
DEX.MI Yearly Shares OutstandingDEX.MI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
DEX.MI Yearly Total Debt VS Total AssetsDEX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • Based on the Altman-Z score of 1.00, we must say that DEX is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 1.00, DEX is not doing good in the industry: 78.13% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of DEX is 38.37, which is on the high side as it means it would take DEX, 38.37 years of fcf income to pay off all of its debts.
  • DEX has a Debt to FCF ratio of 38.37. This is comparable to the rest of the industry: DEX outperforms 43.75% of its industry peers.
  • A Debt/Equity ratio of 0.80 indicates that DEX is somewhat dependend on debt financing.
  • DEX has a worse Debt to Equity ratio (0.80) than 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 38.37
Altman-Z 1
ROIC/WACCN/A
WACC6%
DEX.MI Yearly LT Debt VS Equity VS FCFDEX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.3 Liquidity

  • DEX has a Current Ratio of 1.13. This is a normal value and indicates that DEX is financially healthy and should not expect problems in meeting its short term obligations.
  • DEX has a worse Current ratio (1.13) than 68.75% of its industry peers.
  • DEX has a Quick Ratio of 1.13. This is a bad value and indicates that DEX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of DEX (0.77) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 0.77
DEX.MI Yearly Current Assets VS Current LiabilitesDEX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. DEX.MI Growth Analysis

3.1 Past

  • DEX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -209.70%.
  • DEX shows a decrease in Revenue. In the last year, the revenue decreased by -4.23%.
  • Measured over the past years, DEX shows a very strong growth in Revenue. The Revenue has been growing by 23.78% on average per year.
EPS 1Y (TTM)-209.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-163.11%
Revenue 1Y (TTM)-4.23%
Revenue growth 3Y17.08%
Revenue growth 5Y23.78%
Sales Q2Q%-4.62%

3.2 Future

  • DEX is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -6.47% yearly.
  • DEX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.80% yearly.
EPS Next Y20.14%
EPS Next 2Y12.47%
EPS Next 3Y-6.47%
EPS Next 5YN/A
Revenue Next Year6.67%
Revenue Next 2Y5.46%
Revenue Next 3Y9.8%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DEX.MI Yearly Revenue VS EstimatesDEX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
DEX.MI Yearly EPS VS EstimatesDEX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8 1

More info and screens

Find the best growth stocksShow best growing peers

5

4. DEX.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for DEX. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 4.48 indicates a rather cheap valuation of DEX.
  • 93.75% of the companies in the same industry are more expensive than DEX, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 21.36, DEX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 4.48
DEX.MI Price Earnings VS Forward Price EarningsDEX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DEX is valued a bit more expensive than 71.88% of the companies in the same industry.
  • DEX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. DEX is cheaper than 62.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.73
EV/EBITDA 333.72
DEX.MI Per share dataDEX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • DEX's earnings are expected to decrease with -6.47% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.47%
EPS Next 3Y-6.47%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DEX.MI Dividend Analysis

5.1 Amount

  • DEX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DEX.MI Fundamentals: All Metrics, Ratios and Statistics

DEXELANCE SPA

BIT:DEX (4/30/2026, 2:09:28 PM)

2.59

-0.03 (-1.15%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Industry Strength7.43
Industry Growth19.33
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners13.19%
Inst Owner ChangeN/A
Ins Owners3.17%
Ins Owner ChangeN/A
Market Cap69.75M
Revenue(TTM)457.75M
Net Income(TTM)-22.19M
Analysts85.71
Price Target8.33 (221.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.16%
PT rev (3m)-6.49%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-6.02%
EPS NY rev (3m)-6.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.27%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.48
P/S 0.15
P/FCF 16.73
P/OCF 4.55
P/B 0.47
P/tB N/A
EV/EBITDA 333.72
EPS(TTM)-0.84
EYN/A
EPS(NY)0.58
Fwd EY22.33%
FCF(TTM)0.15
FCFY5.98%
OCF(TTM)0.57
OCFY21.98%
SpS17
BVpS5.54
TBVpS-4.36
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -4.07%
ROE -14.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.22%
FCFM 0.91%
ROA(3y)2.15%
ROA(5y)1.95%
ROE(3y)5.6%
ROE(5y)4.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.52%
GM growth 5Y-2.42%
F-Score3
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 38.37
Debt/EBITDA 287.07
Cap/Depr 49.51%
Cap/Sales 2.44%
Interest Coverage N/A
Cash Conversion 3693.73%
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 0.77
Altman-Z 1
F-Score3
WACC6%
ROIC/WACCN/A
Cap/Depr(3y)40.08%
Cap/Depr(5y)36.04%
Cap/Sales(3y)2.66%
Cap/Sales(5y)2.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-209.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-163.11%
EPS Next Y20.14%
EPS Next 2Y12.47%
EPS Next 3Y-6.47%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.23%
Revenue growth 3Y17.08%
Revenue growth 5Y23.78%
Sales Q2Q%-4.62%
Revenue Next Year6.67%
Revenue Next 2Y5.46%
Revenue Next 3Y9.8%
Revenue Next 5YN/A
EBIT growth 1Y-157.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year91.23%
EBIT Next 3Y30.95%
EBIT Next 5YN/A
FCF growth 1Y-87.24%
FCF growth 3Y-43.61%
FCF growth 5Y-24.56%
OCF growth 1Y-60.86%
OCF growth 3Y-15.86%
OCF growth 5Y-5.5%

DEXELANCE SPA / DEX.MI Fundamental Analysis FAQ

What is the fundamental rating for DEX stock?

ChartMill assigns a fundamental rating of 3 / 10 to DEX.MI.


What is the valuation status for DEX stock?

ChartMill assigns a valuation rating of 5 / 10 to DEXELANCE SPA (DEX.MI). This can be considered as Fairly Valued.


How profitable is DEXELANCE SPA (DEX.MI) stock?

DEXELANCE SPA (DEX.MI) has a profitability rating of 2 / 10.


How sustainable is the dividend of DEXELANCE SPA (DEX.MI) stock?

The dividend rating of DEXELANCE SPA (DEX.MI) is 0 / 10 and the dividend payout ratio is 0%.